1. Home
  2. |Insights
  3. |DoD’s Stocking Stuffer: Defense Department Announces Proposed CMMC Pilot Programs

DoD’s Stocking Stuffer: Defense Department Announces Proposed CMMC Pilot Programs

Client Alert | 1 min read | 12.21.20

This week, the DoD announced the first group of pilot programs under the Cybersecurity Maturity Model Certification. Although still under review, these programs will likely be among a small group to issue solicitations in FY2021 that will require a CMMC certificate to be eligible for award. The DoD expects to identify eight other programs in the coming weeks, bringing the total number of FY2021 solicitations subject to CMMC up to 15. Each program is expected to require a Level 3 certificate for primes, and either a Level 3 or Level 1 certificate for every subcontractor, with limited exceptions.

U.S. Navy

  • Integrated Common Processor
  • F/A-18E/F/ Full Mod of the SBAR and Shut Off Valve
  • DDG-51 Lead Yard Services / Follow Yard Service

U.S. Air Force

  • Mobility Air Force Tactical Data Links
  • Consolidated Broadband Global Area Network Follow-On
  • Azure Cloud Solution

Missile Defense Agency

  • Technical Advisory and Assistance Contract

Insights

Client Alert | 4 min read | 04.18.24

Maryland and Colorado Say the Price Isn’t Right: State Drug Affordability Review Boards Seek Drug Upper Payment Limits

Following federal lawmakers’ initiative to lower prescription drug prices under the Inflation Reduction Act of 2022, several states have taken similar steps to limit certain drugs’ prices. Drug affordability for consumers is a top priority for federal and state lawmakers and regulators because it is a bipartisan issue that directly impacts consumers’ wallets. With negotiations between the federal government and drug manufacturers over 10 drugs’ prices for Medicare beneficiaries well underway under the Inflation Reduction Act, 11 states, including Maryland and Colorado, have created drug affordability review boards to more directly tackle rising prices for both brand and generic drugs.[1] And another 12 states have pending legislation to create these boards.[2] ...